SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-029417
Filing Date
2024-02-29
Accepted
2024-02-29 16:46:06
Documents
17
Period of Report
2024-02-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm247530d1_8k.htm   iXBRL 8-K 27908
2 EXHIBIT 1.1 tm247530d1_ex1-1.htm EX-1.1 20142
3 EXHIBIT 5.1 tm247530d1_ex5-1.htm EX-5.1 16138
7 GRAPHIC tm247530d1_ex5-1img001.jpg GRAPHIC 11586
  Complete submission text file 0001104659-24-029417.txt   263332

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rytm-20240229.xsd EX-101.SCH 3015
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rytm-20240229_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rytm-20240229_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT tm247530d1_8k_htm.xml XML 3619
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 24704623
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)